Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

PLERIXAFOR SEACROSS 20 MG/ML SOLUCION INYECTABLE EFG - CIMA-AEMPS Drug Approval Details

Approvals/CIMA-AEMPS/PLERIXAFOR SEACROSS 20 MG/ML SOLUCION INYECTABLE EFG

Approved

STANDARD

PLERIXAFOR SEACROSS 20 MG/ML SOLUCION INYECTABLE EFG

Seacross Pharma (Europe) Limited🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Date: Jul 10, 2023
Approval ID: 780f2665726ca292
Company: Seacross Pharma (Europe) Limited
Type: Standard

Approval Details

Approval Id: 780f2665726ca292
Drug Cima Aemps Name: PLERIXAFOR SEACROSS 20 MG/ML SOLUCION INYECTABLE EFG
Register Number: 88951
Holder Company Name: Seacross Pharma (Europe) Limited
Marketing Company Name: Pharmavic Iberica S.L.
Authorization Date: 2023-07-10
Dosage Form: SOLUCIÓN INYECTABLE
Dose: 20 mg/ml
Route Of Administration: VÍA SUBCUTÁNEA
Prescription Type: Uso Hospitalario
Commercialized: Yes
Company Name: Seacross Pharma (Europe) Limited

Active Ingredients

PLERIXAFOR

20 mg/ml

Approved

Quick Info

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Jul 10, 2023

Approval ID

780f2665726ca292

Type

Standard

Back to CIMA-AEMPS Approvals